# Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis

> **NCT03493841** · PHASE1 · COMPLETED · sponsor: **Rebecca Spain** · enrollment: 20 (actual)

## Conditions studied

- Multiple Sclerosis
- Progressive Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis
- Primary Progressive Multiple Sclerosis

## Interventions

- **DRUG:** Alpha Lipoic Acid

## Key facts

- **NCT ID:** NCT03493841
- **Lead sponsor:** Rebecca Spain
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-08
- **Primary completion:** 2019-01-25
- **Final completion:** 2019-01-25
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03493841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03493841, "Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03493841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*